What’s moving in the markets


The end of consulting?

Everyone Hates Accenture. Here's Why We're Paying Attention.

Last Thursday, Accenture, the largest consulting firm in the world, dropped 18% after reporting Q3 results. A brutal reaction for a stock already in freefall: investors are now sitting on a -50% loss in 2026 alone. And Accenture isn't alone. Across the consulting space, the carnage is widespread.

To understand what's happening, you first need to understand what these companies actually sell.

Business consulting, at its core, is hiring a third-party expert to solve a specific problem: implementing a new ERP system, rethinking a product strategy, breaking into a new market… It's almost always more expensive than building an in-house team. So why do enterprises keep paying for it?

  1. Speed: A qualified team can be up and running on your problem within days. Hiring in-house? That's months of recruiting, onboarding, and ramp-up time you probably don't have.

  2. Flexibility: What takes days to spin up takes days to wind down. If priorities shift or budgets get cut, you send the consultants home. No severance, no restructuring… no mess.

That value proposition has made Accenture one of the largest employers on the planet: roughly 800,000 people worldwide. And that workforce is the engine behind a deceptively simple business model:

headcount × utilisation rate × hourly rate = revenue

Which brings us to the real problem.

Accenture's Q3 numbers were fine on the surface. But "new bookings" (the forward-looking indicator of future revenue) declined 2% year-over-year. Management also trimmed full-year 2026 revenue guidance. Neither move inspired confidence.

Accenture’s stock has fallen back to 2017 levels

The market isn't worried about Accenture's past. It's worried about its future. Specifically: what happens when AI can do most of what junior consultants do today, but faster, cheaper, and without a billable hour attached?

If AI makes every consultant more productive, the number of hours needed to deliver the same output goes down. Enterprises know this. They'll push for better rates. Competitors will undercut each other to win mandates. The result? A race to the bottom.

The fear isn't that consulting disappears. It's that margins compress as headcounts shrink and firms are forced to deliver more value per hour just to stay relevant.

Needles to say, there's a lot of uncertainty here. But uncertainty isn't the same as a broken business.

Accenture is still growing, despite many things going against it: war in the Middle East, geopolitical noise pushing enterprises to delay large IT commitments, and a technological environment so fast-moving that nobody wants to go all-in on any tech platform while the dust is still settling.

It remains a highly profitable business. And at current prices, management is buying back shares at roughly 7x free cash flow while paying out a dividend yield above 5%.

Whether that's an opportunity depends on what you think comes next.

Selling winners: the hardest part in investing

When your best investment becomes your biggest risk.

20 stocks in the S&P 500 have already doubled or more this year. 19 of them are AI-related. Two of them are in the RatedA portfolio.

If you've been paying attention to markets since 2023, you already know what's been driving this. Semiconductors. Data centres. The infrastructure layer of the AI buildout. If you own anything in that ecosystem, odds are you're sitting on some serious gains right now.

And odds are, those stocks have gone up a lot faster than the underlying businesses have.

20 stocks in the S&P500 have doubled or more in 2026

Here's an investing paradox: the better a stock performs, the worse an investment it can become.

Most people never notice this, because rising prices feel like confirmation. You feel smarter. More optimistic. Validated. But a rising stock price is not the same thing as a better investment.

What often happens is this: the business improves modestly, while the stock improves dramatically. When that gap opens up, future returns start falling. The market has a habit of rewarding investors before proving them right.

That's exactly what's happened across the best-performing AI names over the past two years. The market, betting on an explosion in future profitability, has repriced these businesses as if that future is already here.

Think of it this way: if Company XYZ is expected to generate $10 in earnings per share in two years, the market might price that in today. So what happens in two years when the company actually delivers? Nothing. The stock already moved. The fundamentals are just catching up to the valuation.

This is why a business can double or triple in size, while the stock goes sideways for years. The market isn't broken. The price was just ahead of the business. For investors, this can mean long stretches of mediocre returns on paper-great companies.

So what do you actually do?

You might be holding a stock that's doubled in six months, not because the business transformed overnight, but because expectations did.

Start by asking: what exactly is the market pricing in, and how realistic is it? If the implied scenario feels like a stretch, that's usually your signal to trim or exit. There are always opportunities in the market. Rotating from something overpriced into something better-valued is one of the cleanest ways to de-risk a portfolio without abandoning quality.

But before you sell, consider this:

  1. Just because a stock has doubled doesn’t mean it can’t double again. Great businesses compound through expensive valuations, and selling a true compounder early is one of the most expensive mistakes a long-term investor can make. What looks stretched today can look cheap in three years if the earnings keep growing.

  2. You're not just managing returns, you're managing taxes. If you're sitting on a large gain, the government is effectively giving you an interest-free loan to stay invested. Sell, and you hand back roughly 20-30% in capital gains tax. Let it ride, and that money keeps compounding on your behalf. It's one of the most underrated advantages of holding winners, and one of the core reasons tax-advantaged accounts are such powerful wealth-building tools.

Other Updates


Ratings

  • Boston Scientific (BSX) got a rating initiation

    “Oracle’s growth trajectory is extraordinary, and the ‘revenue obligations’ backlog confirms this momentum is contracted, visible, and accelerating in its conversion to actual revenue. The fundamentals of the business remain firmly intact. The cost of that growth is real, however. The debt Oracle has taken on raises financial risk, and the equity issuance will dilute existing shareholders. Management is making a clear-eyed bet: that the profitability waiting on the other side of this investment cycle justifies the pain of getting there.”

    Click here to view the full update.

Upcoming Earnings

Wednesday

  • Paychex (Q4)

Want to see what we’re actually doing with real money?

Upgrade to unlock full access to the RatedA Portfolio (with weekly updates on every buy/sell and rationale), and the complete database of companies + ratings.

Keep Reading